Past CureTalks
What is Value for Patients in the Management of Prostate Cancer.
At all stages of and levels of prostate cancer, whether you have low, intermediate, or high risk disease, whether you are newly diagnosed, have recurrent disease or your prostate cancer has advanced and metastasized, the same questions arise. What is…
What you need to know about the ICER report and its implication on insurance coverage and treatment options for myeloma patients.
Cancer drugs cost more than $100,000 per year and continue to increase. Medicare has proposed major changes to Medicare Part B in an attempt to slow the explosion in healthcare expenditures. In addition, a recent “report” by a group called…
How Old is “Too Old” for Fertility?
Every woman feels the pressure of time when she has trouble getting pregnant, and running out of time keeps her worrying. The impact of age on fertility is a truth to reckon with, and age related fertility might be a…
The New Optimism of Combination Therapies in Multiple Myeloma Treatment.
Clinical trials of new combination therapies are showing promising results and can be a game changer in myeloma treatment - Combining standard drugs with monoclonal antibodies, t-cell therapies with stem cell transplants, myeloma vaccine combinations and more. We are talking…
Recurrent Miscarriages – Causes and Treatments
Almost half of all pregnancies end in a miscarriage, most of them occurring within few weeks of conception. While there are a number of known risk factors such as maternal age, history of miscarriage, and infertility, there are others like…